Inovio Pharmaceuticals, Inc. (INO) Stock Analysis

Free AI-powered analysis and research for Inovio Pharmaceuticals, Inc. stock

Sector: Healthcare

Analyze Inovio Pharmaceuticals, Inc. (INO) Stock

Inovio Pharmaceuticals, Inc. (INO) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into INO stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Inovio Pharmaceuticals, Inc. stock.

📰 Latest Update

Inovio Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary

Thu, May 14, 2026 at 12:30 PM UTC 4 min read

Inovio Pharmaceuticals reported its Q1 2026 earnings, highlighting progress in its clinical trials and advancements in its DNA medicine platform. The company emphasized its commitment to developing innovative treatments, which could enhance its market position and attract investor interest. Investors should note the potential for future revenue growth as Inovio continues to advance its pipeline and address unmet medical needs.

Read full article →

Why Analyze Inovio Pharmaceuticals, Inc. (INO) with StockIQ?

• ✅ Free AI-powered analysis of Inovio Pharmaceuticals, Inc. (INO) stock
• ✅ Real-time technical indicators for Inovio Pharmaceuticals, Inc. stock
• ✅ Comprehensive risk assessment for INO
• ✅ No credit card required

People also watch